Market Cap
24h Vol
10071
Cryptocurrencies
58.26%
Bitcoin Share

Nasdaq-Listed Company Announces Major Solana (SOL) Purchase – “Like MicroStrategy…”

Nasdaq-Listed Company Announces Major Solana (SOL) Purchase – “Like MicroStrategy…”


BitcoinSistemi
2025-10-06 19:03:08
Nasdaq-Listed Company Announces Major Solana (SOL) Purchase – “Like MicroStrategy…”

Nasdaq-listed Solana Company (formerly Helius Medical Technologies) announced that it has accumulated more than 2.2 million SOL as part of its digital asset treasury strategy. The price of SOL is currently at $235, bringing the total value of the company's SOL assets and cash reserves to approximately $530 million. This amount exceeds the gross proceeds from the company's private sale in September. Related News: Will Pro-Crypto Decisions in the US Be Reversed After Trump? Bitwise CEO Responds Cosmo Jiang, general partner at Pantera Capital and board observer at Solana Company, commented on the matter: “We are following in the footsteps of Michael Saylor at Strategy and Tom Lee at Bitmine. As HSDT Solana Company, we are efficiently accumulating SOL to maximize shareholder value.” Solana Company CEO Joseph Chee stated that institutional interest has been much stronger than expected, particularly following recent digital asset conferences in Asia. This move places Solana Company among the publicly traded companies that consider Solana an asset on their balance sheet. *This is not investment advice. Continue Reading: Nasdaq-Listed Company Announces Major Solana (SOL) Purchase – “Like MicroStrategy…”

Most Read News

Related News


Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.